Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Abstract
Keywords
Cholinesterase inhibitor; Alzheimer’s disease; Bayesian meta-analysis
Bibliographic citation
Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, et al. Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients. Int J Neuropsychopharmacol. 2017 Jul;20(7):519-28.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/6641This item appears in following collections
The following license files are associated with this item: